Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 826 of 1,261
  1. US 8673887

    Non-hormonal steroid modulators of NF-kB for treatment of disease

    ReveraGen BioPharma, Inc. · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  2. US 8674108

    Solid forms of N-[2,4-bis(1,1-dimethylethy)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  3. US 8673333

    Cross-linked polymer matrices, and methods of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  4. US 8672906

    Medical dressing containing antimicrobial agent and related methods therefor

    Covidien LP · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  5. US 8673300

    Therapeutic compositions and methods for the prevention of autoimmune diseases

    The Regents of the University of Colorado, a Body Corporate · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  6. US 8673316

    Avirulent, immunogenic flavivirus chimeras

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  7. US 8673629

    Recombinant Rift Valley fever (RVF) viruses and methods of use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  8. US 8673858

    Method for treating wrinkles using a paralytic peptide from the shrew Blarina brevicauda

    Soricimed Biopharma Inc. · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  9. US 8673843

    NMDA receptors modulators and uses thereof

    Northwestern University · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  10. US 8673375

    Herbal extract products and methods

    Prime Interaction Holdings Limited · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  11. US 8673332

    Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

    Covidien LP · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  12. US 8673301

    YKL-40 monoclonal antibody

    The Regents of the University of California · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  13. US 8673322

    Crystals of laquinimod sodium, and process for the manufacture thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  14. US 8673292

    Pure populations of astrocyte restricted precursor cells and methods for isolation and use thereof

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Mar 18, 2014 · Expires Mar 13, 2034

    granted
  15. US 8668924

    Wound dressing and method for controlling severe, life-threatening bleeding

    Providence Health System—Oregon · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted
  16. US 8669285

    Synthesis, methods of using, and compositions of cycloalkylmethylamines

    REVIVA PHARMACEUTICALS, INC. · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted
  17. US 8668863

    Dendritic macroporous hydrogels prepared by crystal templating

    The Board of Regents of the University of Texas System · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted
  18. US 8669249

    Poly (ADP-ribose) polymerase (PARP) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted
  19. US 8669081

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted
  20. US 8669258

    Treatment for gastroparesis using sepiapterin

    The Board of Regents of the University of Texas System · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted
  21. US 8669283

    Beta-lactones as antibacterial agents

    Ludwig-Maximilians-Universitat Munchen · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted
  22. US 8668911

    Streptococcus vaccine compositions and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted
  23. US 8669101

    Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Mar 11, 2014 · Expires Mar 6, 2034

    granted
  24. CA 2881745

    COMPOSITIONS OPHTALMIQUES CONTENANT DES ACIDES GRAS OMEGA -3

    BAUSCH & LOMB [US] · Granted Mar 6, 2014 · Expires Mar 1, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.